<DOC>
	<DOCNO>NCT00757562</DOCNO>
	<brief_summary>This study conduct evaluate safety tolerance desloratadine 5 week repetitive dose child age 2 12 year old allergic hypersensitivity chronic hive . All subject enrol trial previously identify earlier trial poor metabolizers desloratadine .</brief_summary>
	<brief_title>Safety Desloratadine Children With Allergy Sensitivity Chronic Hives , Who Are Poor Metabolizers Desloratadine ( Study P02994 )</brief_title>
	<detailed_description />
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<criteria>Subjects must : previously identify previous study P03031 atopic chronic idiopathic urticaria poor metabolizer desloratadine . clinical laboratory test within normal limit . good health , free clinically significant disease could interfere study . normal 12lead ECG Subjects : history clinically significant local systemic infectious disease within 4 week prior treatment . take medication restrict protocol fail satisfy washout requirement . allergic desloratadine . use loratadine desloratadinecontaining product within past 30 day . female menstruating .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>